Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:03795637n
Noun Concept
Categories: Drugs that are a monoclonal antibody, Amgen, Osteoporosis drugs, Chemicals that do not have a ChemSpider ID assigned, Drugboxes which contain changes to verified fields
EN
denosumab  AMG-162  Anti-RANK-L antibody  Anti-RANK antibody  Anti-RANKL antibody
EN
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Wikipedia
Definitions
Relations
Sources
EN
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Wikipedia
A drug for treating osteoporosis Wikipedia Disambiguation
Pharmaceutical drug Wikidata
IS A
compound
medicine
monoclonal antibody
biopharmaceutical
MANUFACTURER
Amgen
MEDICAL CONDITION TREATED
fracture
gastroesophageal reflux
esophagitis
hypercalcemia
hyperparathyroidism
+7 relations
PREGNANCY CATEGORY
Australian pregnancy category D
Wikipedia
EN
denosumab
Wikidata
EN
denosumab
Wikipedia Redirections
EN
Anti-RANK-L antibody, Anti-RANK antibody, Anti-RANKL antibody, ATC code M05BX04, ATCvet code QM05BX04, C6404H9912N1724O2004S50, Denotumumab, Prolea, Prolia, RANK-L antibody, RANK-L inhibitor, Xgeva
Wikidata Alias
EN
AMG-162, Prolia, Ranmark Xgeva

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License